5 Results for "

B. proteus

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "B. proteus" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-108307
CAS No.: 66803-19-8
Purity:  ≥98.0%
Synonyms: Gentamicin C2b sulfate; Antibiotic XK-62-2 sulfate; Sagamicin sulfate
Micronomicin sulfate (Gentamicin C2b sulfate) is an aminoglycoside antibiotic isolated from Micromonospora. Micronomicin sulfate is a broad-spectrum antibiotic close to the gentamicin-type antibiotics, exhibits a high activity against Pseudomonas, Proteus, Klebsiella pneumoniae, Serratia, etc (MIC=0.001-8.3 μg/ml) .
loading...
    loading...
Cat. No.: HY-W354851
CAS No.: 67494-15-9
Pisiferic acid is a blood-brain barrier-permeable Kv1.1/Kv1.2 opener and Antibacterial agent. Pisiferic acid has no activity against KCNQ2/3, hERG, or Kv2.1. Pisiferic acid inhibits Perilipin1 and PPARγ protein expression. Pisiferic acid activates PP2C, inhibits PP2B/calcineurin, and induces Apoptosis/Caspase-3/7. Pisiferic acid inhibits macromolecule synthesis in Proteus vulgaris and inhibits DNA/lipid/peptidoglycan synthesis in Bacillus subtilis. Pisiferic acid has antibacterial effects against Proteus vulgaris, Staphylococcus aureus, and Bacillus subtilis. Pisiferic acid can be used for research on episodic ataxia type 1, Kv1.2 loss-of-function channelopathy, obesity, and acute promyelocytic leukemia .
loading...
    loading...
Cat. No.: HY-W777997
CAS No.: 60134-71-6
Nocardicin B is originally isolated from Nocardia uniformis subsp. tsugamanensis ATCC 21806. Nocardicin B only has a weak antibacterial effect on Proteus and axillary bacillus .
loading...
    loading...
Cat. No.: HY-N14872
CAS No.: 189080-83-9
Pyrronamycin B has antibacterial activity against Gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella. Pyrronamycin B also has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-117736
CAS No.: 134452-47-4
Ro 09-1428 is a broad-spectrum parenteral cephalosporin. Ro 09-1428 has potent antibacterial activities against Pseudomonas aeruginosa and Acinetobacter caloaceticus, with MIC90s of 0.39 and 6.25 μg/mL, respectively, better than Ceftazidime (HY-B0593). Additionally, Ro 09-1428 shows high activity against Escherichia coli, Kkbsielia pneumoniae, Proteus mirabilis, P. aeruginosa, staphylococci, and more. Ro 09-1428 preferentially attacks PBP 3 for target in E. coli and P. aeruginosa, which is promising for research of septicemias and serious P. aeruginosa infections .
loading...
    loading...